Fernando Rubio

Fernando Rubio is currently the Local Study Associate Director (LSAD) at AstraZeneca, where they have worked since June 2015, focusing exclusively on oncology studies and contributing to COVID-19 clinical research. Prior to this role, they served as a Clinical Research Associate I at PPD Peru, where they gained experience in a variety of clinical trials including blinded and unblinded studies. With a background as a Project Assistant and Study Coordinator, Fernando possesses extensive expertise in regulatory submissions, monitoring, and the coordination of clinical studies. They hold a Bachelor's degree in Pharmacy from Universidad Nacional de Trujillo and are pursuing a degree in Coaching Profesional.